Controlling pharmaceutical polymorphism in crystallization processes represents a major challenge in pharmaceutical science and engineering. For instance, CO2-antisolvent crystallization typically favors the formation ...

Molecular tautomerism has been reported to play an important role in the crystallization of active pharmaceutical ingredients, particularly in the formation of pharmaceutical cocrystals and salts. In this work, by combining ...